Adderall XR Alternatives Compared
| Adderall XR Remove Adderall XR from your drug comparison | Vyvanse Remove Vyvanse from your drug comparison | Adderall Remove Adderall from your drug comparison |
|---|
| Adderall XR amphetamine / dextroamphetamine Remove Adderall XR from your drug comparison | Vyvanse lisdexamfetamine Remove Vyvanse from your drug comparison | Adderall amphetamine / dextroamphetamine Remove Adderall from your drug comparison | ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adderall XR is a long-acting, once-daily formulation that combines four different amphetamine salts into one product and is used for the treatment of ADHD. Adderall XR is potentially addictive and... View more |
Vyvanse is a stimulant used in the treatment of ADHD and BED. It is potentially addictive and there have been reports of serious cardiac side effects in adults and children. Prescribed for Binge... View more |
Adderall is a combination of four different amphetamine salts and is used for the treatment of ADHD or narcolepsy. Adderall is potentially addictive and can cause insomnia. Prescribed for ADHD,... View more |
||||||||||||||||||||||||
|
Prescription only |
Prescription only |
Prescription only |
||||||||||||||||||||||||
Ratings & Reviews |
||||||||||||||||||||||||||
Drug Class |
||||||||||||||||||||||||||
Side Effects |
||||||||||||||||||||||||||
|
Common side effects include: headache, insomnia, weight loss, anorexia, xerostomia. See the full Adderall XR side effects document. |
Common side effects include: insomnia, irritability. See the full Vyvanse side effects document. |
See the full Adderall side effects document. |
||||||||||||||||||||||||
Pricing and Coupons* Prices are without insurance |
||||||||||||||||||||||||||
View all Adderall XR prices and generic prices |
View all Vyvanse prices |
View all Adderall prices and generic prices |
||||||||||||||||||||||||
Generic Availability |
||||||||||||||||||||||||||
|
No |
||||||||||||||||||||||||||
Dosage Form(s) Available |
||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
Brand Names |
||||||||||||||||||||||||||
| Other amphetamine / dextroamphetamine brands include: Adderall, Mydayis |
N/A |
Other amphetamine / dextroamphetamine brands include: Adderall XR, Mydayis | ||||||||||||||||||||||||
Half LifeThe half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. |
||||||||||||||||||||||||||
|
34 hours |
1 hour |
34 hours |
||||||||||||||||||||||||
CSA Schedule**View glossary of terms. |
||||||||||||||||||||||||||
|
High potential for abuse
Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence. |
High potential for abuse
Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence. |
High potential for abuse
Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence. |
||||||||||||||||||||||||
Pregnancy Category |
||||||||||||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full Pregnancy Warnings document. |
Category C
Risk cannot be ruled out
See the full Pregnancy Warnings document. |
Category C
Risk cannot be ruled out
See the full Pregnancy Warnings document. |
||||||||||||||||||||||||
FDA Alerts |
||||||||||||||||||||||||||
Drug Interactions |
||||||||||||||||||||||||||
|
A total of 179 drugs are known to interact with Adderall XR:
|
A total of 328 drugs are known to interact with Vyvanse:
|
A total of 179 drugs are known to interact with Adderall:
|
||||||||||||||||||||||||
Alcohol/Food/Lifestyle Interactions |
||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
Disease Interactions |
||||||||||||||||||||||||||
First Approval Date |
||||||||||||||||||||||||||
|
October 11, 2001 |
February 23, 2007 |
January 19, 1960 |
||||||||||||||||||||||||
WADA ClassView World Anti-Doping Agency classifications. |
||||||||||||||||||||||||||
|
N/A |
N/A |
|||||||||||||||||||||||||
More Information |
||||||||||||||||||||||||||
Consumer Resources |
||||||||||||||||||||||||||
Professional Resources |
||||||||||||||||||||||||||
Related Treatment Guide |
||||||||||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.